Ascendis Pharma's growth hormone formally approved in the EU

On Thursday, the European Commission has officially approved Ascendis Transcon hGH, which was given a positive recommendation from the European Medicines Agency.
Photo: Kevin Grønnemann / MedWatch
Photo: Kevin Grønnemann / MedWatch
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen

Following a positive recommendation from the European Medicines Agency (EMA), the European Commission has officially approved Ascendis Pharma's Lonapegsomatropin, Ascendis announces in a press release.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must contain at least 6 characters
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading